Cargando…
Could a Shigella vaccine impact long-term health outcomes?: Summary report of an expert meeting to inform a Shigella vaccine public health value proposition, March 24 and 29, 2021
Shigellosis is a leading cause of diarrhea and dysentery in young children from low to middle-income countries and adults experiencing traveler’s diarrhea worldwide. In addition to acute illness, infection by Shigella bacteria is associated with stunted growth among children, which has been linked t...
Autores principales: | Bagamian, Karoun H., Puett, Chloe, Anderson, John D., Muhib, Farzana, Pecenka, Clint, Behrman, Jere, Breiman, Robert F., Edoka, Ijeoma, Horton, Susan, Kang, Gagandeep, Kotloff, Karen L., Lanata, Claudio F., Platts-Mills, James A., Qadri, Firdausi, Rogawski McQuade, Elizabeth T., Sudfeld, Christopher, Vonaesch, Pascale, Wierzba, Thomas F., Scheele, Suzanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551074/ https://www.ncbi.nlm.nih.gov/pubmed/36237199 http://dx.doi.org/10.1016/j.jvacx.2022.100218 |
Ejemplares similares
-
Projecting the long-term economic benefits of reducing Shigella-attributable linear growth faltering with a potential vaccine: a modelling study
por: Puett, Chloe, et al.
Publicado: (2023) -
Potential impact and cost-effectiveness of Shigella vaccination in 102 low-income and middle-income countries in children aged 5 years or younger: a modelling study
por: Anderson, John D, et al.
Publicado: (2023) -
Potential impact and cost-effectiveness of future ETEC and Shigella vaccines in 79 low- and lower middle-income countries
por: Anderson, John D., et al.
Publicado: (2019) -
Pivotal Shigella Vaccine Efficacy Trials—Study Design Considerations from a Shigella Vaccine Trial Design Working Group
por: Pavlinac, Patricia B., et al.
Publicado: (2022) -
Shigella and childhood stunting: Evidence, gaps, and future research directions
por: Bagamian, Karoun H., et al.
Publicado: (2023)